儿童哮喘急诊静脉硫酸镁使用差异:PECARN登记研究
OBJECTIVE: To examine the use, efficacy, and safety of intravenous magnesium sulfate (IVMg) in children with asthma whose emergency department (ED) management is recorded in the Pediatric Emergency Care Applied Research Network (PECARN) Registry.…
要点
- 儿童哮喘急诊IVMg总体使用率10.5%,住院患儿中25.7%,各中心差异大。
- IVMg给药偏晚,中位时间154分钟,且使用差异无法用患者特征解释。
- IVMg后离院者72小时内返诊率与未用IVMg者无差异,离院可能安全。
核心结论
- 在PECARN登记急诊中,IVMg给药偏晚,仅用于少数可能受益的患儿,且各中心使用差异大,提示IVMg预防住院的当前临床作用有限。
- IVMg后离院可能安全,需前瞻性研究评估早期IVMg的有效性和安全性。
研究设计与样本
- 多中心回顾性队列研究,分析2012至2017年7个急诊科2-17岁急性哮喘患儿的临床数据。
主要发现
- IVMg给药后11.1%的患者从急诊离院回家,6.8%发生低血压。
- IVMg使用差异无法用患者特征解释,IVMg后离院者与未用IVMg者的返诊率无差异。
临床怎么用
- 儿科急诊医生应知IVMg在哮喘急诊中使用率低且给药偏晚,各中心差异大。
- 对于IVMg后病情稳定的患儿,可考虑离院并告知返诊风险与未用IVMg者无差异。
局限性
- 本研究为回顾性队列研究,仅纳入PECARN登记中7个急诊科的数据,可能存在未测量混杂。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To examine the use, efficacy, and safety of intravenous magnesium sulfate (IVMg) in children with asthma whose emergency department (ED) management is recorded in the Pediatric Emergency Care Applied Research Network (PECARN) Registry. STUDY DESIGN: This multicenter retrospective cohort study analyzed clinical data from 7 EDs from 2012 to 2017. We described use of IVMg in children aged 2-17 years treated for acute asthma and its effect on blood pressure. We also used multivariable analysis to examine factors associated with use of IVMg and its association with return visits within 72 hours. RESULTS: Across 61 854 asthma visits for children, clinicians administered IVMg in 6497 (10.5%). Median time from triage to IVMg administration was 154 minutes (IQR 84, 244). During 22 495 ED visits resulting in hospitalization after ED treatment, IVMg was administered in 5774 (25.7%) (range by site 15.9%, 50.6%). Patients were discharged home from the ED after 11.1% of IVMg administrations, and hypotension occurred after 6.8%. Variation in IVMg use was not explained by patient characteristics. Revisits did not differ between patients discharged after IVMg and those not receiving IVMg. CONCLUSIONS: In PECARN Registry EDs, administration of IVMg occurs late in ED treatment, for a minority of the children likely to benefit, with variation between sites, which suggests the current clinical role for IVMg in preventing hospitalization is limited. Discharge after IVMg administration is likely safe. Further research should prospectively assess the efficacy and safety of early IVMg administration.
引用
- Johnson MD, Zorc JJ, Nelson DS, et al. Intravenous Magnesium in Asthma Pharmacotherapy: Variability in Use in the PECARN Registry. J Pediatr. 2020. PMID: 32147221. doi:10.1016/j.jpeds.2020.01.062
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。